These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29334844)

  • 1. The molecular signature of AML with increased ALDH activity suggests a stem cell origin.
    Blume R; Rempel E; Manta L; Saeed BR; Wang W; Raffel S; Ermakova O; Eckstein V; Benes V; Trumpp A; Ho AD; Lutz C
    Leuk Lymphoma; 2018 Sep; 59(9):2201-2210. PubMed ID: 29334844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
    Schuurhuis GJ; Meel MH; Wouters F; Min LA; Terwijn M; de Jonge NA; Kelder A; Snel AN; Zweegman S; Ossenkoppele GJ; Smit L
    PLoS One; 2013; 8(11):e78897. PubMed ID: 24244383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential.
    Cheung AM; Wan TS; Leung JC; Chan LY; Huang H; Kwong YL; Liang R; Leung AY
    Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.
    Ran D; Schubert M; Pietsch L; Taubert I; Wuchter P; Eckstein V; Bruckner T; Zoeller M; Ho AD
    Exp Hematol; 2009 Dec; 37(12):1423-34. PubMed ID: 19819294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.
    Daga S; Rosenberger A; Quehenberger F; Krisper N; Prietl B; Reinisch A; Zebisch A; Sill H; Wölfler A
    Cancer Med; 2019 Apr; 8(4):1771-1778. PubMed ID: 30848055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.
    Venton G; Pérez-Alea M; Baier C; Fournet G; Quash G; Labiad Y; Martin G; Sanderson F; Poullin P; Suchon P; Farnault L; Nguyen C; Brunet C; Ceylan I; Costello RT
    Blood Cancer J; 2016 Sep; 6(9):e469. PubMed ID: 27611922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of ALDH as a Potential Biomarker and Therapeutic Target for AML.
    Yang X; Yao R; Wang H
    Biomed Res Int; 2018; 2018():9192104. PubMed ID: 29516013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells.
    Bogen A; Buske C; Hiddemann W; Bohlander SK; Christ O
    Exp Hematol; 2017 Mar; 47():54-63. PubMed ID: 27826122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and separation of normal hematopoietic stem cells and leukemia stem cells from patients with acute myeloid leukemia.
    Hoang VT; Hoffmann I; Borowski K; Zepeda-Moreno A; Ran D; Buss EC; Wuchter P; Eckstein V; Ho AD
    Methods Mol Biol; 2013; 1035():217-30. PubMed ID: 23959995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cells can be separated from leukemic cells in a subgroup of adult acute lymphoblastic leukemia patients.
    Wang W; Foerner E; Buss E; Jauch A; Eckstein V; Wuchter P; Ho AD; Lutz C
    Leuk Lymphoma; 2017 Jun; 58(6):1446-1454. PubMed ID: 27734718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.
    Gerber JM; Smith BD; Ngwang B; Zhang H; Vala MS; Morsberger L; Galkin S; Collector MI; Perkins B; Levis MJ; Griffin CA; Sharkis SJ; Borowitz MJ; Karp JE; Jones RJ
    Blood; 2012 Apr; 119(15):3571-7. PubMed ID: 22262762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.
    Goardon N; Marchi E; Atzberger A; Quek L; Schuh A; Soneji S; Woll P; Mead A; Alford KA; Rout R; Chaudhury S; Gilkes A; Knapper S; Beldjord K; Begum S; Rose S; Geddes N; Griffiths M; Standen G; Sternberg A; Cavenagh J; Hunter H; Bowen D; Killick S; Robinson L; Price A; Macintyre E; Virgo P; Burnett A; Craddock C; Enver T; Jacobsen SE; Porcher C; Vyas P
    Cancer Cell; 2011 Jan; 19(1):138-52. PubMed ID: 21251617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JmjC-domain containing histone demethylase 1B-mediated p15(Ink4b) suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia.
    Nakamura S; Tan L; Nagata Y; Takemura T; Asahina A; Yokota D; Yagyu T; Shibata K; Fujisawa S; Ohnishi K
    Mol Carcinog; 2013 Jan; 52(1):57-69. PubMed ID: 22086844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.
    Storms RW; Green PD; Safford KM; Niedzwiecki D; Cogle CR; Colvin OM; Chao NJ; Rice HE; Smith CA
    Blood; 2005 Jul; 106(1):95-102. PubMed ID: 15790790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples.
    Pearce DJ; Taussig D; Simpson C; Allen K; Rohatiner AZ; Lister TA; Bonnet D
    Stem Cells; 2005; 23(6):752-60. PubMed ID: 15917471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells.
    Jin L; Lee EM; Ramshaw HS; Busfield SJ; Peoppl AG; Wilkinson L; Guthridge MA; Thomas D; Barry EF; Boyd A; Gearing DP; Vairo G; Lopez AF; Dick JE; Lock RB
    Cell Stem Cell; 2009 Jul; 5(1):31-42. PubMed ID: 19570512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity.
    Hess DA; Meyerrose TE; Wirthlin L; Craft TP; Herrbrich PE; Creer MH; Nolta JA
    Blood; 2004 Sep; 104(6):1648-55. PubMed ID: 15178579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia.
    De Grandis M; Bardin F; Fauriat C; Zemmour C; El-Kaoutari A; Sergé A; Granjeaud S; Pouyet L; Montersino C; Chretien AS; Mozziconacci MJ; Castellano R; Bidaut G; Boher JM; Collette Y; Mancini SJC; Vey N; Aurrand-Lions M
    Cancer Res; 2017 Dec; 77(23):6627-6640. PubMed ID: 28972073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.